Literature DB >> 26831572

Macular pigmentation of uncertain aetiology revisited: two case reports and a proposed algorithm for clinical classification.

Veena Chandran1, Sujith Prasad Kumarasinghe2.   

Abstract

Ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus and idiopathic eruptive macular pigmentation are various types of acquired macular hyperpigmentation disorders of the skin described in literature. However, a global consensus on the definitions of these entities is lacking. We report two cases of acquired macular (hyper)pigmentation of uncertain aetiology diagnosed as ashy dermatosis and attempt to clarify the various confusing nosologies based on existing literature. We infer that acquired small and large macular pigmentation of uncertain aetiology should be considered separate from that associated with lichen planus. We also propose a diagnostic algorithm for patients with acquired macular hyperpigmentation.
© 2016 The Australasian College of Dermatologists.

Entities:  

Keywords:  ashy dermatosis; erthema dyschromicum perstans; idiopathic eruptive macular pigmentation; lichen planus pigmentosus

Mesh:

Year:  2016        PMID: 26831572     DOI: 10.1111/ajd.12428

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  3 in total

1.  Periorbital Acquired Dermal Macular Hyperpigmentation: A Distinctive Clinical Entity in Young Adults-Observational Case-Control Study.

Authors:  T Muhammed Razmi; Vishal Thakur; Keshavamurthy Vinay; Divya Aggarwal; Bishan D Radotra; Muthu Sendhil Kumaran; Davinder Parsad
Journal:  Indian Dermatol Online J       Date:  2020-07-13

Review 2.  Lichen Planus Pigmentosus: The Controversial Consensus.

Authors:  Aparajita Ghosh; Arijit Coondoo
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

3.  Ashy Dermatosis and Lichen Planus Pigmentosus: The Histopathological Differences.

Authors:  Suthinee Rutnin; Siriorn Udompanich; Nathathai Pratumchart; Sarawin Harnchoowong; Vasanop Vachiramon
Journal:  Biomed Res Int       Date:  2019-10-28       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.